HomeINZY • NASDAQ
add
Inozyme Pharma Inc
Previous close
$1.42
Day range
$3.94 - $3.96
Year range
$0.72 - $6.24
Market cap
255.02M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.79M | 5.93% |
Net income | -28.04M | -20.10% |
Net profit margin | — | — |
Earnings per share | -0.44 | -15.79% |
EBITDA | -25.61M | -6.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 84.78M | -48.98% |
Total assets | 95.16M | -46.22% |
Total liabilities | 63.37M | 9.05% |
Total equity | 31.80M | — |
Shares outstanding | 64.56M | — |
Price to book | 2.90 | — |
Return on assets | -59.05% | — |
Return on capital | -70.29% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -28.04M | -20.10% |
Cash from operations | -29.15M | -18.82% |
Cash from investing | 33.68M | 224.07% |
Cash from financing | 228.00K | 43.40% |
Net change in cash | 4.76M | 134.11% |
Free cash flow | -18.31M | -7.58% |
About
Founded
2015
Headquarters
Website
Employees
67
